Current evidence does not support prescribing GLP-1 medications solely for psoriasis management
Semaglutide is part of a class of medications that mimic a natural hormone (GLP-1) which helps regulate blood sugar and appetite
In addition to the glycemic control, these agents have shown considerable cardiovascular advantages that have been confirmed by large-scale cardiovascular outcome trials (CVOTs) that have shown reductions in major adverse cardiovascular events (MACE), including myocardial infarction (MI), stroke, and cardiovascular death [6,7]
Side Effects The most frequently reported adverse reactions in clinical trials were gastrointestinal disorders, including nausea (very common), diarrhoea (very common) and vomiting (common)
Many patients begin noticing appetite changes within weeks, while visible fat loss may become more apparent after 612 weeks
After stopping glutathione, the body gradually returns to relying solely on its natural glutathione production and antioxidant defenses
